NCT02721043 2021-01-11Safety and Immunogenicity of Personalized Genomic Vaccine to Treat MalignanciesIcahn School of Medicine at Mount SinaiPhase 1 Completed13 enrolled
NCT00046735 2019-11-18Phase 1 Study OF CDC-501 in Patients With Solid TumorsCelgenePhase 1 Completed24 enrolled
NCT01750983 2019-02-25Ipilimumab and Lenalidomide in Advanced CancerM.D. Anderson Cancer CenterPhase 1 Completed101 enrolled